TickerFacts.

NRX Pharmaceuticals, Inc. (NRXP): Revenue

Annual figures by period end, from SEC filings.

$1.45M
Year ended 2025-12-31
$3.61M
Trailing 12 months to 2026-06-30
2023-12-31: $02024-12-31: $02025-12-31: $1.45M$1.45M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.45Mn/a2026-03-23, From 2025-01-01
2024-12-31$0n/a2025-03-14, From 2024-01-01
2023-12-31$0n/a2025-03-14, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$1.45Mn/a
Avenue Therapeutics, Inc. (ATXI)2025-12-31$1.40Mn/a
Northwest Biotherapeutics Inc (NWBO)2025-12-31$1.38M-0.3%
Cannapharmarx, Inc. (CPMD)2025-12-31$1.36M+66.1%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$1.63M+58.9%
IGC Pharma, Inc. (IGC)2025-03-31$1.27M-5.5%
Vistagen Therapeutics, Inc. (VTGN)2026-03-31$1.27M+161.1%
Longeveron Inc. (LGVN)2025-12-31$1.20M-49.9%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$1.17M-92.5%

Compare NRXP, ATXI, NWBO, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗